| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 49 companies in the Life Sciences Tools & Services industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 29, 2025 | NTRA Natera, Inc. | Fesko John | President, Chief Bus. Officer | Sell | 4,030 | $165.87 | $668,453.90 | -0.9% | -7.9% | +37.6% | |
| Jan 29, 2025 | NTRA Natera, Inc. | Moshkevich Solomon | President, Clinicaldiagnostics | Sell | 5,201 | $165.87 | $862,687.58 | -1.3% | -7.9% | +37.6% | |
| Jan 29, 2025 | NTRA Natera, Inc. | Chapman Steven Leonard56 | CEO And President | Sell | 13,685 | $165.87 | $2,269,928.10 | -1.3% | -7.9% | +37.6% | |
| Jan 28, 2025 | PSNL Personalis, Inc. | Tachibana Aaron68 | CFO And COO | Sell | 708 | $5.79 | $4,099.32 | -0.4% | -31.1% | +83.6% | |
| Jan 28, 2025 | PSNL Personalis, Inc. | Chen Richard70 | Chief Medical Officer And EVP | Sell | 519 | $5.79 | $3,005.01 | -0.4% | -31.1% | +83.6% | |
| Jan 28, 2025 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 47,537 | $1.47 | $70,060.03 | - | -6.0% | -14.7% | |
| Jan 27, 2025 | NTRA Natera, Inc. | Brophy Michael Burkes47 | Chief Financial Officer | Sell | 1,442 | $161.87 | $233,416.54 | -1.3% | -7.4% | +45.4% | |
| Jan 24, 2025 | NTRA Natera, Inc. | Brophy Michael Burkes47 | Chief Financial Officer | Sell | 1,441 | $171.67 | $247,378.24 | -0.4% | -7.8% | +44.1% | |
| Jan 23, 2025 | TWST Twist Bioscience Corp | Finn Patrick John73 | President And COO | Sell | 2,422 | $50.17 | $121,500.60 | -0.9% | -29.4% | -19.4% | |
| Jan 22, 2025 | NTRA Natera, Inc. | Fesko John | President, Chief Bus. Officer | Sell | 21,228 | $164.97 | $3,501,904.81 | -6.7% | -15.9% | +41.3% | |
| Jan 22, 2025 | NTRA Natera, Inc. | Moshkevich Solomon | President, Clinicaldiagnostics | Sell | 24,861 | $164.97 | $4,101,226.45 | -8.1% | -15.9% | +41.3% | |
| Jan 22, 2025 | NTRA Natera, Inc. | Chapman Steven Leonard56 | CEO And President | Sell | 78,553 | $164.97 | $12,958,585.02 | -12.8% | -15.9% | +41.3% | |
| Jan 22, 2025 | NTRA Natera, Inc. | Sheena Jonathan46 | Director, Co-founder | Sell | 971 | $165.00 | $160,214.01 | -0.2% | -15.9% | +41.3% | |
| Jan 22, 2025 | NTRA Natera, Inc. | Rabinowitz Daniel48 | Sec. And Chief Legal Officer | Sell | 22,039 | $164.97 | $3,635,684.56 | -4.8% | -15.9% | +41.3% | |
| Jan 22, 2025 | NTRA Natera, Inc. | Brophy Michael Burkes47 | Chief Financial Officer | Sell | 25,931 | $164.97 | $4,277,735.15 | -10.6% | -15.9% | +41.3% | |
| Jan 21, 2025 | A Agilent Technologies, Inc. | McDonnell Padraig71 | President And CEO | Sell | 1,911 | $150.00 | $286,650.00 | -4.6% | -34.3% | -8.4% | |
| Jan 17, 2025 | GH Guardant Health, Inc. | Tariq Musa | Director | Sell | 116 | $37.58 | $4,359.28 | -3.8% | +22.7% | +205.9% | |
| Jan 17, 2025 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 150,000 | $1.47 | $220,425.00 | - | -3.4% | -12.9% | |
| Jan 15, 2025 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 500,000 | $1.48 | $740,850.00 | +0.2% | -2.0% | -12.9% | |
| Jan 14, 2025 | IMDX Insight Molecular Diagnostics Inc. | Smith Patrick W66 | 10% Owner | Buy | 16,055 | $2.12 | $34,114.42 | +0.3% | +32.3% | +218.6% | |
| Jan 13, 2025 | CSTL Castle Biosciences Inc | Maetzold Derek J69 | Pres. &Chief Exec. Officer | Sell | 2,565 | $28.03 | $71,902.93 | -0.4% | -23.9% | +51.6% | |
| Jan 10, 2025 | TWST Twist Bioscience Corp | Laponis Adam58 | Chief Financial Officer | Sell | 5,886 | $43.26 | $254,646.02 | -5.1% | -16.0% | -19.0% | |
| Jan 8, 2025 | NTRA Natera, Inc. | Rabinowitz Daniel48 | Sec. And Chief Legal Officer | Sell | 6,223 | $175.30 | $1,090,901.23 | -3.0% | -25.1% | +35.6% | |
| Jan 7, 2025 | TWST Twist Bioscience Corp | Chess Robert84 | Director | Sell | 5,000 | $50.00 | $250,000.00 | -23.1% | -18.9% | -19.9% | |
| Jan 7, 2025 | WGS Genedx Holdings Corp. | Stueland Katherine | Chief Executive Officer | Sell | 51,420 | $94.48 | $4,858,118.95 | -44.7% | -12.6% | +40.7% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.